LeonaBio LONA
NASDAQ LONA
$4.82 +0.44 (+10.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

LeonaBio (LONA) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

LeonaBio (LONA) posted Return on Capital Employed [ROCE] of -216.40% for Q2 2026, down 46.73 percentage points from -169.68% a year earlier and down 70.21 percentage points from the prior quarter.

Analysis

LeonaBio (LONA) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, LeonaBio's Return on Capital Employed [ROCE] came in at -365.73%, down 261.04 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for five consecutive years, with a five-year change of -351.08 percentage points (FY2020 to FY2025).
  • In prior years, LeonaBio's Return on Capital Employed [ROCE] was -104.70% in FY2024 (-35.13 pp), -69.56% in FY2023 (-31.55 pp), -38.01% in FY2022 (-16.42 pp) and -21.59% in FY2021 (-6.94 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -752.56% in Q4 2025 to a high of -15.78% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -106.79 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2026, with a gain of 35.06 percentage points; the weakest was Q4 2025, with a drop of 582.63 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -146.19% (Q1 2026), -752.56% (Q4 2025) and -130.88% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 LeonaBio 114.36 Mn -117.94 Mn - -216.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -216.40%
Mar 31, 2026 -146.19%
Dec 31, 2025 -752.56%
Sep 30, 2025 -130.88%
Jun 30, 2025 -169.68%
Mar 31, 2025 -181.26%
Dec 31, 2024 -169.93%
Sep 30, 2024 -161.06%
Jun 30, 2024 -125.48%
Mar 31, 2024 -101.76%
Dec 31, 2023 -87.35%
Sep 30, 2023 -77.13%
Jun 30, 2023 -59.61%
Mar 31, 2023 -49.00%
Dec 31, 2022 -42.50%
Sep 30, 2022 -32.94%
Jun 30, 2022 -28.54%
Mar 31, 2022 -24.48%
Dec 31, 2021 -19.38%
Sep 30, 2021 -15.78%
API Access

LeonaBio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LONA&period=max&api_key=YOUR_API_KEY